Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov;81(11):e223.
doi: 10.1136/annrheumdis-2020-218910. Epub 2020 Sep 7.

Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases' by Giollo et al

Kimme L Hyrich  1 , Milena Gianfrancesco  2 , Pedro M Machado  3   4 , Jinoos Yazdany  5 , Philip C Robinson  6   7
Affiliations
Comment

Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases' by Giollo et al

Kimme L Hyrich et al. Ann Rheum Dis. 2022 Nov.
No abstract available

Keywords: autoimmunity; glucocorticoids; inflammation.

PubMed Disclaimer

Conflict of interest statement

Competing interests: KLH reports she has received speaker’s fees from Abbvie and grant income from BMS, UCB and Pfizer, all unrelated to this article. KLH is also supported by the NIHR Manchester Biomedical Research Centre. MG reports grants from National Institutes of Health, NIAMS, outside the submitted work. JY reports personal fees from Astra Zeneca and Eli Lilly, and grants from Pfizer, outside the submitted work. PMM reports personal fees from Abbvie, Eli Lilly, Novartis and UCB, outside the submitted work. PCR reports personal fees from Abbvie, Eli Lilly, Janssen, Pfizer, UCB and Novartis; and non-financial support from BMS and Roche outside the submitted work.

Comment on

Substances